Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 101 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,761,370 | -21.0% | 323,187 | -1.6% | 0.00% | – |
Q2 2023 | $2,230,665 | +47.3% | 328,522 | +8.7% | 0.00% | – |
Q1 2023 | $1,514,668 | -3.1% | 302,329 | -5.6% | 0.00% | – |
Q4 2022 | $1,563,605 | -67.0% | 320,411 | -2.6% | 0.00% | -100.0% |
Q3 2022 | $4,745,000 | -5.8% | 329,023 | -1.2% | 0.00% | 0.0% |
Q2 2022 | $5,039,000 | +29.6% | 333,098 | +1.8% | 0.00% | 0.0% |
Q1 2022 | $3,888,000 | -30.3% | 327,253 | -4.9% | 0.00% | 0.0% |
Q4 2021 | $5,576,000 | -43.7% | 343,987 | -0.9% | 0.00% | -50.0% |
Q3 2021 | $9,904,000 | -15.4% | 347,034 | +0.2% | 0.00% | 0.0% |
Q2 2021 | $11,709,000 | +12.0% | 346,406 | +0.2% | 0.00% | 0.0% |
Q1 2021 | $10,457,000 | -40.2% | 345,801 | -2.1% | 0.00% | -33.3% |
Q4 2020 | $17,483,000 | +21.7% | 353,099 | -5.6% | 0.00% | 0.0% |
Q3 2020 | $14,365,000 | -12.3% | 374,196 | -1.3% | 0.00% | -25.0% |
Q2 2020 | $16,384,000 | +111.7% | 379,256 | +27.9% | 0.00% | +100.0% |
Q1 2020 | $7,738,000 | -14.3% | 296,486 | +2.6% | 0.00% | 0.0% |
Q4 2019 | $9,029,000 | +40.1% | 288,898 | +16.8% | 0.00% | 0.0% |
Q3 2019 | $6,446,000 | +147.2% | 247,326 | +116.9% | 0.00% | +100.0% |
Q2 2019 | $2,608,000 | +22.1% | 114,023 | +39.9% | 0.00% | 0.0% |
Q1 2019 | $2,136,000 | +39.3% | 81,492 | +8.2% | 0.00% | – |
Q4 2018 | $1,533,000 | – | 75,329 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |